Methyltestosterone


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000014 Abnormalities, Drug-Induced PMID:29458080
MESH:D002779 Cholestasis PMID:26881866; PMID:27344345; PMID:9487641
MESH:D004428 Ear Neoplasms PMID:2414260
MESH:D006528 Carcinoma, Hepatocellular PMID:15495253; PMID:4117807; PMID:48615
MESH:D006529 Hepatomegaly PMID:28108177
MESH:D007414 Intestinal Neoplasms PMID:2414260
MESH:D007674 Kidney Diseases PMID:19761811
MESH:D008103 Liver Cirrhosis PMID:4117807
MESH:D010049 Ovarian Diseases PMID:29191790
MESH:D010259 Paranoid Disorders PMID:4585769
MESH:D011471 Prostatic Neoplasms PMID:2414260
MESH:D011472 Prostatitis PMID:3148599
MESH:D012878 Skin Neoplasms PMID:2414260
MESH:D014770 Virilism PMID:29191790
MESH:D014973 Xanthomatosis PMID:5124256
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:26881866; PMID:33814510; PMID:4117807

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.